Meisoindigo is a derivative of indirubin with antitumor activity, which has been used in China for chronic myeloid leukemia. Meisoindigo is an apoptosis inducer and potential agent for the treatment of AML. It inhibits the growth of leukemic cells by inducing marked apoptosis and moderate cell-cycle arrest at the G(0)/G(1) phase. Source summary: Methylisoindigotin for research use: chemical compound for biochemical studies and synthesis, with clear identification for lab workflows.
Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Inflammation / Immunology | Apoptosis Inducer
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye